
Dear Stoner: Does America still have a competitive spot among the rest of the world in the legal-cannabis space? Are we still leading?
Rece
Dear Stoner: Does America still have a competitive spot among the rest of the world in the legal-cannabis space? Are we still leading?
Rece
The forced resignation of Attorney General Jeff Sessions may have much larger implications for where Robert Mueller’s investigation into President Donald Trump is heading, but ousting ol’ Jeffy was a score for the marijuana industry.
While immigration, health care and gun control continue to divide the country, at least one issue is starting to bring us together: legalizing cannabis.
Amendment X, a ballot measure that takes industrial hemp out of the Colorado Constitution, passed by a narrow margin on Tuesday, November 6. The proposal needed 55 percent approval from voters to succeed, and it currently sits at slightly over 60 percent, with more than 90 percent of the state’s votes counted.
A lawsuit filed by two Colorado landowners who claim that a nearby marijuana grow has reduced their property values in part because the smell makes horseback riding less pleasant goes to trial in Denver federal court today. And the repercussions of the suit’s strategy, based on federal racketeering laws, could have far-reaching effects on the cannabis industry in Colorado and beyond.
Once Canada began its cannabis legalization efforts, investors’ eyes shifted from the fragmented state policies in America to a federal government up north that was open for business. The money soon followed: Reports of massive investments from companies like Molson-Coors and rumors of interest from Coca-Cola continue to swirl around Canada’s new legal cannabis sector (legalization will officially begin October 17) — and Colorado brands have taken notice.
Since 2013, the Rocky Mountain High Intensity Drug Trafficking Area, a federally funded law-enforcement organization, has been issuing highly critical, persistently biased reports about the impact of marijuana legalization in Colorado.
Add Dixie Elixirs to the list of Colorado cannabis companies continuing to expand north of the border. The pot-infused-products company just announced plans to go public on the Canadian Securities Exchange pending approval from the CSE.
The Drug Enforcement Administration appeared to take a large step forward on Thursday, September 27, when it confirmed that it would reclassify Epidiolex as a Schedule V substance. The move follows Food and Drug Administration approval and classifies the marijuana-derived cannabidiol (CBD) medication under the DEA’s lowest restriction for drugs, so physicians and pharmacies can now prescribe and dispense it in all fifty states under federal law.
Has the Trump administration secretly organized a committee of federal agencies to “combat public support for marijuana,” as Buzzfeed reported on August 29? The article describes White House memos and emails instructing fourteen federal agencies and the Drug Enforcement Administration to submit “data demonstrating the most significant negative trends” about marijuana to the Marijuana Policy Coordination Committee.